[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100394752":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":32,"responsibleParty":133,"collaborators":136,"id":157,"slug":158,"hasResults":159,"nctId":160,"briefTitle":161,"officialTitle":162,"acronym":163,"eligibilityCriteria":164,"healthyVolunteers":165,"sex":166,"minAge":10,"maxAge":167,"enrollmentInfo":168,"targetDuration":10,"studyType":171,"phases":10,"briefSummary":172,"conditions":173,"keywords":175,"overallStatus":57,"whyStopped":10,"lastUpdateSubmitDate":179,"lastUpdatePostDateStruct":180,"startDateStruct":183,"completionDateStruct":185,"leadSponsor":187,"locationsCount":188},{"fullName":5,"class":6},"Oregon Health and Science University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"i-ROP cohort",null,"Premature infants who are at risk of retinopathy of prematurity(ROP) at participating study sites. As standard of care, babies who are born less than 31 weeks gestational age or less than 1500 grams are routinely screened for ROP. Families are approached to participate in this study where finding from babies' eye exams and associated retinal images along with demographic and other health data are collected and coded with unique identifier. No intervention is administered. The ROP exams and images obtained are done as a standard of care and would be performed even if there is no consent provided.",[13],"Other: No intervention administered.",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"No intervention administered.","Eye exams are standard of care and would be performed regardless of participation in this study.",[9],[20],{"name":21,"affiliation":5,"role":22},"John P Campbell, M.D.","PRINCIPAL_INVESTIGATOR",[24,28],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","503-494-7891","campbelp@ohsu.edu",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Susan R Ostmo, M.S.","503-494-7450","ostmo@ohsu.edu",[33,55,75,94,113],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Stanford University","NOT_YET_RECRUITING","Palo Alto","California","94303","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-122.14302,37.44188,{"lat":45,"lon":44},[48,52],{"name":49,"role":25,"phone":50,"phoneExt":10,"email":51},"Darius Moshfeghi, M.D.","650-723-6995","dariusm@stanford.edu",{"name":53,"role":25,"phone":50,"phoneExt":10,"email":54},"Mariana Nunez","mnunez1@stanford.edu",{"facility":56,"status":57,"city":58,"state":59,"zip":60,"country":39,"countryCode":40,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"University of Illinois Chicago","RECRUITING","Chicago","Illinois","60607",{"type":42,"coordinates":62},[63,64],-87.65005,41.85003,{"lat":64,"lon":63},[67,71],{"name":68,"role":25,"phone":69,"phoneExt":10,"email":70},"Robison Vernon P Chan, M.D.","312-996-6660","rvpchan@uic.edu",{"name":72,"role":25,"phone":73,"phoneExt":10,"email":74},"Bhavana Kolli","630-863-1487","bkolli2@uic.edu",{"facility":76,"status":57,"city":77,"state":78,"zip":79,"country":39,"countryCode":40,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"William Beaumont Hospital","Royal Oak","Michigan","48073",{"type":42,"coordinates":81},[82,83],-83.14465,42.48948,{"lat":83,"lon":82},[86,90],{"name":87,"role":25,"phone":88,"phoneExt":10,"email":89},"Kimberly Drenser, M.D.","248-288-2280","kdrenser@arcpc.net",{"name":91,"role":25,"phone":92,"phoneExt":10,"email":93},"Mary Zajechowski","248-330-7649","mary.zajechowski@beaumont.org",{"facility":95,"status":57,"city":96,"state":97,"zip":98,"country":39,"countryCode":40,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"Oregon Health & Science University","Portland","Oregon","97239",{"type":42,"coordinates":100},[101,102],-122.67621,45.52345,{"lat":102,"lon":101},[105,106,108,111],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},{"name":107,"role":25,"phone":30,"phoneExt":10,"email":31},"Susan R Osmto, M.S.",{"name":109,"role":110,"phone":10,"phoneExt":10,"email":10},"Aaron Coyner, PhD","SUB_INVESTIGATOR",{"name":112,"role":110,"phone":10,"phoneExt":10,"email":10},"Kemal Sonmez, PhD",{"facility":114,"status":35,"city":115,"state":116,"zip":117,"country":39,"countryCode":40,"cosmosGeoPoint":118,"geoPoint":122,"contacts":123},"University of Utah","Salt Lake City","Utah","84132",{"type":42,"coordinates":119},[120,121],-111.89105,40.76078,{"lat":121,"lon":120},[124,128,131],{"name":125,"role":25,"phone":126,"phoneExt":10,"email":127},"Mary E Hartnett, M.D.","801-581-2352","me.hartnett@hsc.utah.edu",{"name":129,"role":25,"phone":126,"phoneExt":10,"email":130},"Deborah Harrison","deborah.harrison@hsc.utah.edu",{"name":132,"role":110,"phone":10,"phoneExt":10,"email":10},"Leah Owen, M.D.",{"type":22,"investigatorFullName":134,"investigatorTitle":135,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Michael Chiang","Principal Investigator",[137,140,143,145,147,149,151,153,154,155],{"name":138,"class":139},"National Institutes of Health (NIH)","NIH",{"name":141,"class":142},"U.S. National Science Foundation","FED",{"name":144,"class":6},"Massachusetts General Hospital",{"name":146,"class":6},"Northeastern University",{"name":148,"class":6},"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center",{"name":150,"class":6},"Corewell Health East",{"name":152,"class":6},"University of Illinois at Chicago",{"name":34,"class":6},{"name":114,"class":6},{"name":156,"class":139},"National Eye Institute (NEI)","100394752","clinical-and-genetic-analysis-of-rop-100394752",false,"NCT04420156","Clinical and Genetic Analysis of ROP","Clinical and Genetic Analysis of Retinopathy of Prematurity","(ROP)","Inclusion Criteria:\n\n* All infants hospitalized at participating Neonatal Intensive Care Units will be eligible for the study if they meet plublished criteria for requiring ROP screening examination, or if they are transferred to the study center for specialized ophthalmic care. These eligibility criteria are identical at each study center, and match what is done in standard clinical practice according to national guidelines published jointly by the American Academy of Pediatrics, American Academy of Ophthalmology, and American Associatioin for Pediatric Ophthalmology and Strabismus (AAP-AAO, Pediatrics, 2013).\n\nExclusion Criteria:\n\n* Patients will be excluded if they have structural ocular anomalies, or if they are considered unstable for examintion by their attending neonatologist.",true,"ALL","1 Year",{"count":169,"type":170},2000,"ESTIMATED","OBSERVATIONAL","Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel that this study will result in specific knowledge discovery about ROP, as well as general knowledge about how image-based data and genetic data can be combined to better understand clinical disease.\n\nParticipants will be recruited from the neonatal intensive care unit (NICU) at OHSU, along with 4 collaborating institutions (William Beaumont Hospital, Stanford University, University of Illinois Chicago and University of Utah). Hospitalized infants who receive ROP screening examinations for routine care will be eligible for this study, and will be offered the opportunity to participate. Subjects who provide informed consent will have clinical data from routine care collected along with demographic characteristics, results from routine ROP screening examinations, presence of systemic disease or risk factors. Retinal photographs will be taken during these routine eye exams, using a commercially-available camera that has been FDA-cleared for taking pictures from retinas of premature infants. These retinal pictures do not contain any identifiable patient information, and are taken as routine standard of care.\n\nThe long-term goal of this research is to establish a quantitative framework for retinopathy of prematurity (ROP) care based on clinical, imaging, genetic, and informatics principles. The investigators have previously recruited and rigorously phenotyped and genotyped a large study cohort, including implementation of a novel reference standard diagnosis; and built a world-class research consortium for image, genetic, and bioinformatics analysis.",[174],"Retinopathy of Prematurity",[176,177,178],"ophthalmology","neonatology","prematurity","2022-04-18",{"date":181,"type":182},"2022-04-20","ACTUAL",{"date":184,"type":182},"2011-07-01",{"date":186,"type":170},"2030-05-31",{"name":5,"class":6},5]